Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Memory Impairment in Parkinson's Disease
NCT04643327Phase 2Recruiting
- Sponsor
- The University of Queensland
- Start
- Feb 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in Mild Cognitive Impairment (MCI), Memory impairment, sponsored by The University of Queensland. Started Feb 2021; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
Mild Cognitive Impairment (MCI)Memory impairment
Beyond the preview
Go deeper on NCT04643327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643327.